Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belinostat with carboplatin and paclitaxel in untreated carcinoma of unknown primary
NCT00873119Phase 2Completed
- Sponsor
- Valerio Therapeutics
- Start
- Feb 2009
- Primary completion
- Dec 2012
- Countries
- 4
01
Overview
Phase 2, randomised, open-label trial of belinostat in carcinoma of unknown primary (CUP) (2 arms), sponsored by Valerio Therapeutics. Primary endpoint: Progression-Free Survival. Started Feb 2009; status: completed.
02
Drugs
belinostat
03
Conditions
carcinoma of unknown primary (CUP)
Beyond the preview
Go deeper on NCT00873119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00873119.